Cargando…

PReS-FINAL-2342: Anti-TNFALPHA therapy targeys PKB/C-AKT induced resistance of effector cells to suppression in juvenile arthritis

Detalles Bibliográficos
Autores principales: Wehrens, E, Vastert, S, Mijnheer, G, Meerding, J, Klein, M, Wulffraat, N, Prakken, B, van Wijk, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042260/
http://dx.doi.org/10.1186/1546-0096-11-S2-P332
_version_ 1782318782085070848
author Wehrens, E
Vastert, S
Mijnheer, G
Meerding, J
Klein, M
Wulffraat, N
Prakken, B
van Wijk, F
author_facet Wehrens, E
Vastert, S
Mijnheer, G
Meerding, J
Klein, M
Wulffraat, N
Prakken, B
van Wijk, F
author_sort Wehrens, E
collection PubMed
description
format Online
Article
Text
id pubmed-4042260
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40422602014-06-17 PReS-FINAL-2342: Anti-TNFALPHA therapy targeys PKB/C-AKT induced resistance of effector cells to suppression in juvenile arthritis Wehrens, E Vastert, S Mijnheer, G Meerding, J Klein, M Wulffraat, N Prakken, B van Wijk, F Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4042260/ http://dx.doi.org/10.1186/1546-0096-11-S2-P332 Text en Copyright © 2013 Wehrens et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Wehrens, E
Vastert, S
Mijnheer, G
Meerding, J
Klein, M
Wulffraat, N
Prakken, B
van Wijk, F
PReS-FINAL-2342: Anti-TNFALPHA therapy targeys PKB/C-AKT induced resistance of effector cells to suppression in juvenile arthritis
title PReS-FINAL-2342: Anti-TNFALPHA therapy targeys PKB/C-AKT induced resistance of effector cells to suppression in juvenile arthritis
title_full PReS-FINAL-2342: Anti-TNFALPHA therapy targeys PKB/C-AKT induced resistance of effector cells to suppression in juvenile arthritis
title_fullStr PReS-FINAL-2342: Anti-TNFALPHA therapy targeys PKB/C-AKT induced resistance of effector cells to suppression in juvenile arthritis
title_full_unstemmed PReS-FINAL-2342: Anti-TNFALPHA therapy targeys PKB/C-AKT induced resistance of effector cells to suppression in juvenile arthritis
title_short PReS-FINAL-2342: Anti-TNFALPHA therapy targeys PKB/C-AKT induced resistance of effector cells to suppression in juvenile arthritis
title_sort pres-final-2342: anti-tnfalpha therapy targeys pkb/c-akt induced resistance of effector cells to suppression in juvenile arthritis
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042260/
http://dx.doi.org/10.1186/1546-0096-11-S2-P332
work_keys_str_mv AT wehrense presfinal2342antitnfalphatherapytargeyspkbcaktinducedresistanceofeffectorcellstosuppressioninjuvenilearthritis
AT vasterts presfinal2342antitnfalphatherapytargeyspkbcaktinducedresistanceofeffectorcellstosuppressioninjuvenilearthritis
AT mijnheerg presfinal2342antitnfalphatherapytargeyspkbcaktinducedresistanceofeffectorcellstosuppressioninjuvenilearthritis
AT meerdingj presfinal2342antitnfalphatherapytargeyspkbcaktinducedresistanceofeffectorcellstosuppressioninjuvenilearthritis
AT kleinm presfinal2342antitnfalphatherapytargeyspkbcaktinducedresistanceofeffectorcellstosuppressioninjuvenilearthritis
AT wulffraatn presfinal2342antitnfalphatherapytargeyspkbcaktinducedresistanceofeffectorcellstosuppressioninjuvenilearthritis
AT prakkenb presfinal2342antitnfalphatherapytargeyspkbcaktinducedresistanceofeffectorcellstosuppressioninjuvenilearthritis
AT vanwijkf presfinal2342antitnfalphatherapytargeyspkbcaktinducedresistanceofeffectorcellstosuppressioninjuvenilearthritis